- Home
- HBIO vs GDL Comparison
HBIO vs GDL Comparison
Compare HBIO & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- GDL
- Stock Information
- Founded
- HBIO 1901
- GDL 2006
- Country
- HBIO United States
- GDL United States
- Employees
- HBIO N/A
- GDL N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- GDL Investment Managers
- Sector
- HBIO Industrials
- GDL Finance
- Exchange
- HBIO Nasdaq
- GDL Nasdaq
- Market Cap
- HBIO 19.6M
- GDL 93.8M
- IPO Year
- HBIO 2000
- GDL N/A
- Fundamental
- Price
- HBIO $0.44
- GDL $8.30
- Analyst Decision
- HBIO Buy
- GDL
- Analyst Count
- HBIO 2
- GDL 0
- Target Price
- HBIO $3.00
- GDL N/A
- AVG Volume (30 Days)
- HBIO 1.1M
- GDL 11.2K
- Earning Date
- HBIO 08-07-2025
- GDL 01-01-0001
- Dividend Yield
- HBIO N/A
- GDL 6.02%
- EPS Growth
- HBIO N/A
- GDL N/A
- EPS
- HBIO N/A
- GDL N/A
- Revenue
- HBIO $91,397,000.00
- GDL N/A
- Revenue This Year
- HBIO N/A
- GDL N/A
- Revenue Next Year
- HBIO $9.75
- GDL N/A
- P/E Ratio
- HBIO N/A
- GDL N/A
- Revenue Growth
- HBIO N/A
- GDL N/A
- 52 Week Low
- HBIO $0.28
- GDL $7.65
- 52 Week High
- HBIO $3.60
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- HBIO 49.18
- GDL 49.06
- Support Level
- HBIO $0.42
- GDL $8.25
- Resistance Level
- HBIO $0.48
- GDL $8.37
- Average True Range (ATR)
- HBIO 0.05
- GDL 0.07
- MACD
- HBIO -0.01
- GDL -0.01
- Stochastic Oscillator
- HBIO 24.69
- GDL 36.69
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.